KCI Commences Tender Offer for All Outstanding Shares of LifeCell Corporation for $51.00 per Share in Cash

  
    
  
  
    
      Kinetic Concepts, Inc. (NYSE: KCI) and LifeCell Corporation (Nasdaq: 
      LIFC) today announced the commencement of the tender offer by Leopard 
      Acquisition Sub, Inc., a wholly-owned subsidiary of Kinetic Concepts, 
      Inc., for all outstanding shares of LifeCell common stock at a price of 
      $51.00 per share, net to the seller in cash. The tender offer is 
      being made pursuant to an Offer to Purchase, dated April 21, 2008, in 
      connection with the Agreement and Plan of Merger, which is dated and was 
      previously announced on April 7, 2008.
    
    
      The tender offer is scheduled to expire at 12:00 midnight, New York City 
      Time, on May 16, 2008, unless the tender offer is extended. Following 
      the completion of the tender offer, KCI expects to consummate a merger 
      pursuant to which any remaining LifeCell shares not purchased in the 
      tender offer will be acquired for the same cash price per share as paid 
      in the tender offer. The obligation to accept for payment and pay for 
      the shares of common stock of LifeCell tendered in the tender offer is 
      subject to customary conditions, including, among other things: the 
      tender of a majority of the total number of outstanding shares of 
      LifeCell common stock (calculated on a fully diluted basis), the 
      expiration or termination of any waiting period (and any extensions 
      thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, 
      as amended and completion of financing pursuant to the terms of an 
      executed commitment letter among Kinetic Concepts, Inc. and the lenders 
      party thereto, dated April 7, 2008 (or an alternative financing on 
      substantially similar terms).
    
    
      The complete terms and conditions of the tender offer are set out in the 
      tender offer statement (including the Offer to Purchase, Letter of 
      Transmittal and other related tender offer materials), which was filed 
      today by Kinetic Concepts, Inc. with the U.S. Securities and Exchange 
      Commission. LifeCell has also filed today a solicitation/ recommendation 
      statement with respect to the offer on Schedule 14D-9. LifeCell 
      stockholders and other investors should read these materials carefully 
      because they contain important information, including the terms and 
      conditions of the offer. LifeCell shareholders and other investors may 
      obtain copies of these documents free of charge at the SEC’s 
      web site (www.sec.gov); or from The 
      Laurel Hill Advisory Group, the information agent for the offer, 
      toll-free at [phone]. Additional information regarding the tender 
      offer may be obtained from J.P. Morgan Securities Inc., the dealer 
      manager for the offer, toll-free at [phone].
    
    
      Securities Law Disclosure
    
    
      This press release is neither an offer to purchase nor a solicitation of 
      an offer to sell securities. The tender offer is being made pursuant to 
      a tender offer statement and related materials. LifeCell’s 
      stockholders are advised to read the tender offer statement and related 
      materials, as filed by Kinetic Concepts, Inc. with the U.S. Securities 
      and Exchange Commission (the “SEC”). 
      The tender offer statement (including the Offer to Purchase, letter of 
      transmittal and related tender offer documents) filed by Kinetic 
      Concepts, Inc. with the SEC and the solicitation/ recommendation 
      statement with respect to the offer on Schedule 14D-9 filed by LifeCell 
      with the SEC contain important information which should be read 
      carefully before any decision is made with respect to the tender offer. 
      The tender offer statement and the solicitation/recommendation statement 
      will be mailed to all LifeCell stockholders of record.
    
    
      Forward Looking Statements
    
    
      This communication contains forward-looking statements, which may be 
      identified by words such as “believes”, 
      “expects”, “anticipates”, 
      “estimates”, “projects”, 
      “intends”, “should”, 
      “seeks”, “future”, 
      “continue”, or the 
      negative of such terms, or other comparable terminology. Forward-looking 
      statements are subject to risks, uncertainties, assumptions and other 
      factors that are difficult to predict and that could cause actual 
      results to vary materially from those expressed in or indicated by them, 
      including the risk that the tender offer may not be completed or the 
      merger may not be consummated for various reasons, including the failure 
      to satisfy the conditions precedent to the completion of the 
      acquisition. Additional risks and factors are identified in KCI’s 
      and LifeCell’s filings with the U.S. 
      Securities Exchange Commission (the “SEC”), 
      including their respective Annual Reports on Form 10-K for the fiscal 
      year ending December 31, 2007, which are available on the SEC’s 
      website at http://www.sec.gov. The 
      information contained in this press release is as of April 21, 2008. 
      Except as required by law, neither KCI nor LifeCell undertake any 
      obligation to revise or update any forward-looking statement, or to make 
      any other forward-looking statements, whether as a result of new 
      information, future events or otherwise.